FindTrial
Sign In

pegylated interferon alfa

BIOLOGICAL8 trials

Sponsors

Memorial Sloan Kettering Cancer Center, European Organisation for Research and Treatment of Cancer - EORTC, National Cancer Institute (NCI), Merck Sharp & Dohme LLC, Vanderbilt-Ingram Cancer Center

Conditions

Chronic Hepatitis CDiffuse Intrinsic Pontine GliomaHepatitis D, ChronicIntraocular MelanomaKidney CancerLymphomaMelanomaMelanoma (Skin)

Phase 1

Interferon Alfa in Treating Patients With Advanced Kidney Cancer
CompletedNCT00003542
Memorial Sloan Kettering Cancer CenterKidney Cancer
Start: 1998-05-31End: 2004-04-30Target: 58Updated: 2013-06-25

Phase 2

A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
CompletedNCT00036569
National Cancer Institute (NCI)Diffuse Intrinsic Pontine Glioma
Start: 2002-05-31End: 2012-01-31Updated: 2012-02-13
Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma
CompletedNCT00027742
Memorial Sloan Kettering Cancer CenterIntraocular Melanoma, Melanoma (Skin)
Start: 2001-05-31End: 2005-06-30Updated: 2013-06-05
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma
CompletedNCT00006039
Memorial Sloan Kettering Cancer CenterLymphoma, Small Intestine Cancer
Start: 1999-12-31End: 2001-03-31Updated: 2013-06-19
A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
CompletedNCT00118768
Merck Sharp & Dohme LLCChronic Hepatitis C
Start: 2005-08-31Target: 175Updated: 2009-03-02
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
NCT03105310
Aga Khan UniversityHepatitis D, Chronic
Start: 2016-01-31End: 2017-06-30Target: 20Updated: 2017-04-07

Phase 3

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
NCT00006249
European Organisation for Research and Treatment of Cancer - EORTCMelanoma (Skin)
Start: 2000-06-30Updated: 2015-02-10

Unknown Phase

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
TerminatedNCT00897312
Vanderbilt-Ingram Cancer CenterMelanoma
Start: 2006-10-31End: 2008-08-31Updated: 2016-04-25

Related Papers

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
2008-07-01423 citations